These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38513315)

  • 1. Development of a highly sensitive and green first-derivative synchronous fluorescence spectroscopic method for the simultaneous quantification of telmisartan and rosuvastatin: Greenness metric assessment and application to a pharmacokinetic study in rats.
    Ramzy S; Abduljabbar MH; Alosaimi ME; Almalki AH
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124164. PubMed ID: 38513315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
    Chae DW; Son M; Kim Y; Son H; Jang SB; Seo JM; Nam SY; Park K
    Int J Clin Pharmacol Ther; 2015 Oct; 53(10):883-9. PubMed ID: 26329347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study.
    Son M; Guk J; Kim Y; Woo Chae D; Heo YA; Soh D; Park K
    Clin Ther; 2016 Aug; 38(8):1845-57. PubMed ID: 27422590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between rosuvastatin and telmisartan in healthy Korean male volunteers: a randomized, open-label, two-period, crossover, multiple-dose study.
    Son M; Kim Y; Lee D; Roh H; Son H; Guk J; Jang SB; Nam SY; Park K
    Clin Ther; 2014 Aug; 36(8):1147-58. PubMed ID: 24998012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
    Kim TS; Rha SW; Kim SY; Park DG; Sung KC; Yoon MH; Kim KH; Lee HC; Kim WS; Kim YJ; Ahn JC; Rhee MY; Cha DH; Yoo BS; Park SH; Yoo KD; Jeon DW; Yoon YW; Cho SK; Oh YS
    Clin Ther; 2019 Apr; 41(4):728-741. PubMed ID: 30904178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
    Hong SJ; Jeong HS; Cho JM; Chang K; Pyun WB; Ahn Y; Hyon MS; Kang WC; Lee JH; Kim HS
    Clin Ther; 2019 Feb; 41(2):233-248.e9. PubMed ID: 30665829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study.
    Oh GC; Han JK; Han KH; Hyon MS; Doh JH; Kim MH; Jeong JO; Bae JH; Kim SH; Yoo BS; Baek SH; Rhee MY; Ihm SH; Sung JH; Choi YJ; Kim SJ; Hong KS; Lee BK; Cho J; Shin ES; Rhew JY; Kim H; Kim HS
    Clin Ther; 2018 May; 40(5):676-691.e1. PubMed ID: 29673890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green fluorometric strategy for simultaneous determination of the antihypertensive drug telmisartan (A tentative therapeutic for COVID-19) with Nebivolol in human plasma.
    Salim MM; Radwan AS; Hadad GM; Belal F; Elkhoudary MM
    Sci Rep; 2023 Mar; 13(1):3576. PubMed ID: 36864220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous Spectrofluorimetry Coupled with Third-Order Derivative Signal Processing for the Simultaneous Quantitation of Telmisartan and Chlorthalidone Drug Combination in Human Plasma.
    Elsonbaty A; Hasan MA; Eissa MS; Hassan WS; Abdulwahab S
    J Fluoresc; 2021 Jan; 31(1):97-106. PubMed ID: 33089428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects.
    Kim CH; Kang SI; Shin D
    Adv Ther; 2021 Feb; 38(2):1094-1105. PubMed ID: 33326064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin.
    Hu M; Lee HK; To KK; Fok BS; Wo SK; Ho CS; Wong CK; Zuo Z; Chan TY; Chan JC; Tomlinson B
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1471-1478. PubMed ID: 27651239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia.
    Jin X; Kim MH; Han KH; Hong SJ; Ahn JC; Sung JH; Cho JM; Lee HC; Choi SY; Lee K; Kim WS; Rhee MY; Kim JH; Hong SP; Yoo BS; Cho EJ; Lee JH; Kim PJ; Park CG; Hyon MS; Shin JH; Lee SH; Sung KC; Hwang J; Kwon K; Chae IH; Seo JS; Kim H; Lee H; Cho Y; Kim HS
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1835-1845. PubMed ID: 32937023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of rosuvastatin and propranolol in their binary mixture by synchronous spectrofluorimetry.
    El-Abasawi NM; Attia KAM; Abo-Serie AAM; Morshedy S; Abdel-Fattah A
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jun; 198():322-330. PubMed ID: 29567601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of synchronous spectrofluorimetric method for the simultaneous determination of duvelisib and moxifloxacin: greenness metric assessment and application to a pharmacokinetic study in rats.
    Othman WM; Al-Zoman NZ; Darwish IA; Almomen A; Farid NF; Abdallah FF; Saad SS
    Methods Appl Fluoresc; 2023 Dec; 12(1):. PubMed ID: 38052071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination.
    Mistry RP; Shah C; Jat R
    Folia Med (Plovdiv); 2022 Feb; 64(1):103-109. PubMed ID: 35851888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel sustainable second-derivative synchronous spectrofluorimetric method for the simultaneous determination of olmesartan medoxomil and rosuvastatin calcium in bulk and formulations: Integrated greenness and whiteness evaluation.
    Batakoushy HA; Nasr ZA; Soliman MM; Barghash SS; Fouad FA; Barseem A
    Luminescence; 2023 Dec; ():. PubMed ID: 38062646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of green first derivative synchronous spectrofluorometric method for quantitative analysis of fexofenadine hydrochloride and pseudoephedrine hydrochloride in pharmaceutical preparation and spiked human plasma.
    Ramzy S; Abdelazim AH; Hasan MA
    BMC Chem; 2022 Aug; 16(1):62. PubMed ID: 35986381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green spectrofluorimetric quantification of aspirin, olmesartan, and metoprolol in spiked human plasma.
    Alqahtani A; Alqahtani T; Gahtani RM; Ramzy S
    Sci Rep; 2023 Nov; 13(1):20182. PubMed ID: 37978204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.
    Choi J; Sung KC; Ihm SH; Yoon CH; Park SW; Park SH; Kim JY; Kwon SU; Lee HY
    J Clin Hypertens (Greenwich); 2021 Sep; 23(9):1664-1674. PubMed ID: 34384001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New ecological first derivative synchronous spectrofluorimetric method for simultaneous quantification of carvedilol and ivabradine in tablets.
    Rashad EA; Elsayed SS; Nasr JJM; Ibrahim FA
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Mar; 289():122074. PubMed ID: 36508901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.